Month: August 2022

Posted on

Diabsolut Acquires Emelar Consulting Group, a Full-Service Salesforce Consulting Firm With Expertise That Includes Manufacturing and Revenue Management

Both firms gain added proficiency in Salesforce Field Service, Revenue Cloud, CPQ, and Billing.

Diabsolut Acquires Emelar Consulting Group

Diabsolut Acquires Emelar Consulting Group

MONTREAL, Aug. 01, 2022 (GLOBE NEWSWIRE) — Salesforce expert and innovative cloud solution provider Diabsolut announced that they have acquired Emelar Consulting Group. Emelar is a Salesforce consulting partner specializing in CPQ and Salesforce Field Service, who is known for their success in assisting manufacturing organizations address business concerns.

The overall goal of the acquisition was to increase the amount of experience, services, benefits, and value delivered to both Diabsolut and Emelar’s clients.

“As a close-knit organization that strives to provide exceptional value and returns for our clients, we are delighted to join forces with a like-minded organization in Diabsolut,” said Jesse Theiler, founder and CEO of Emelar. 

“Our combined commitment to client empowerment will provide clients with even deeper Salesforce expertise, particularly Salesforce Field Service, additional experience and capabilities with enterprise clients, and the ability to provide FinancialForce solutions across new verticals,” Mr. Theiler stated, “We’re eager to bring our CPQ expertise and deep manufacturing sector experience to Diabsolut.”

On continuing Emelar’s philanthropy post-acquisition, Mr. Theiler said, “I’m excited about our cultural alignment and, importantly, we’ve gained a great partner in our ongoing mission to provide support for young adults with autism and raising autism awareness. This is a perfect situation for our clients, partners and staff alike.”

After the acquisition of Foundry52 in 2021, the acquisition of Emelar will further cement Diabsolut’s reputation as Field Service and Revenue Cloud experts, while expanding the capabilities they offer for manufacturing organizations.

“We are elated to have found an organization like Emelar, who is so closely aligned with our culture and dedication for delivering customer success,” said Elie Hossari, President of Diabsolut. “Jesse’s mission for Emelar, his community outreach, Emelar’s passion for helping clients reach their goals in the best way possible — Emelar and Diabsolut’s values come from the same playbook, and we’re looking forward to a great future together.”

Mr. Hossari continued, “We’re also excited to put Emelar’s manufacturing experience together with our enterprise experience, to continue to grow our capabilities in the Manufacturing, Automotive and Energy segment, and add a pool of high-quality senior technical resources with specialties in Manufacturing, Revenue Cloud, CPQ, and Billing. Ultimately, we are increasing short- and long-term benefits for both current and future clients.”

Our services and combined expertise:

  • Implementations and Integrations
  • Advisory and Managed Services
  • Development and Support
  • Change Management & Training
  • Talent Management
  • Field Service and Asset Management
  • CPQ, Billing and Revenue
  • CRM / Customer 360 Platform / Communities
  • Higher Education and Not for Profit
  • FinancialForce ERP

ABOUT Emelar Consulting Group

Emelar Consulting Group is a Salesforce consulting partner specializing in CPQ and Salesforce Field Service, which helps organizations significantly improve performance, efficiencies, and bottom-line results through the Salesforce platform. We have proven successes in supporting manufacturing organizations of all sizes to solve big business problems.

ABOUT Diabsolut

Diabsolut is a Salesforce Summit Consulting Partner and has been a FinancialForce partner since 2014. We have nearly 20 years of experience implementing Salesforce, Field Service, Revenue, and Higher Education solutions throughout North America. Our team of experts is uniquely positioned to identify and resolve the challenges that many organizations face, with rapid time to value results no matter where they are in their transformation journey.

Media Contact Info:

Andy Prince

Chief Innovation Officer, Diabsolut Inc.

T: 514-461-3314 x140 | E: aprince@diabsolut.com

Related Images

Image 1: Diabsolut Acquires Emelar Consulting Group

Announcement welcoming the Emelar Consulting Group to the Diabsolut family.

This content was issued through the press release distribution service at Newswire.com.

Attachment

Posted on

N2Growth Rapidly Expanding Latin America Search Operations, Adding New Partner in Brazil

Firm Appoints Luiz Gustavo Aranha, CEO of RSG Brasil Headhunters, as Partner.

  1. N2Growth Logo

N2Growth Logo

PHILADELPHIA, Aug. 01, 2022 (GLOBE NEWSWIRE) — N2Growth Inc., a global leadership consulting and executive search firm, announced today its expansion to Brazil with the appointment of Luiz Gustavo Aranha as Partner. Luiz will be responsible for all operations in Brazil and neighboring countries and will report directly to Kelli Vukelic, CEO at N2Growth.

“Supporting our expansion into Latin America, particularly in Brazil, is a crucial pillar in our goal to better serve clients worldwide, especially in Central and South America. Luiz brings an exceptional track record of superior client delivery and experience in the financial services market, construction and engineering sector, and technology, mining, and consumer goods industries. We are excited to see further growth under his leadership,” said Ms. Vukelic.

The firm’s firm’s newest location in São Paulo, Brazil is led by Mr. Aranha, founder & CEO of RSG Brasil. He brings over 15 years of professional experience in the recruitment of mid-to-senior level executives in Brazil and across Latin America. He specializes in complex and strategic roles for clients who seek quality, speed, and confidentiality in finding the best executive leaders.

Mr. Aranha added, “This partnership with N2Growth shows confidence in the market and a great opportunity to improve the recruitment and selection of executives in a market with few  competitors that demand a service of excellence and development of executives in companies.”

Founded in 2007, RSG Brasil Headhunters is a recruitment and leadership advisory firm in São Paulo, Brazil, that Mr. Aranha founded. The firm made a name for itself by supporting organizations in evaluating talent and preparing businesses for the future of leadership, working with prominent brands, such as  Paynet, Dexco, Sacyr Constructions, and Grupo Carrefour. RSG Brasil engages in a wide range of activities in the market, filling vacancies in various sectors of the economy.

“The executive search segment has been operating in the same way for years, and changes are overdue to respond more accurately and quickly to the needs of our clients. N2Growth brings an innovative and proven solution to Latin American markets. Unsurprisingly, Forbes ranks N2Growth as one of America’s Best Executive Recruiting Firms. This partnership brings the Brazilian market a global excellence operation with exclusive methodology and tools. With N2Growth as a partner, we will have all the resources needed to recruit the best and develop outstanding leaders,” said Mr. Aranha.

N2Growth’s partnership with Mr. Aranha solidifies the firm’s commitment to building and establishing permanent operations throughout Latin America and supporting our global network of premiere talent through retained search engagements, executive coaching, and leadership assessments.

About N2Growth

N2Growth is a global leadership consulting and executive search firm, consistently ranked in the Top 10 Best Executive Recruiting Firms by Forbes and serves more than 50 markets across the Americas, EMEA, and APAC.

Media Inquiries:

Dan Evans

CMO, N2Growth

press@n2growth.com

Related Images

Image 1: N2Growth Logo

N2Growth Executive Search

This content was issued through the press release distribution service at Newswire.com.

Attachment

Posted on

AOP Health Starts Research for Leukemia Treatment

AOP Health signed an agreement with Leukos Biotech for the further development of a newly discovered chemical substance. With this agreement AOP Health expands the hemato-oncology research area even further and provides additional treatment options for certain leukemia patients in the longer term.

Agnes Kohl, Chief Business Officer, AOP Orphan Pharmaceuticals GmbH, Member of the AOP Health Group

Photo credit: Studio Koekart: Natascha Unkart & Isabelle Köhler

VIENNA, Austria, Aug. 01, 2022 (GLOBE NEWSWIRE) — The AOP Health Group (AOP Health) is a European pioneer for integrated therapies for rare diseases and in critical care headquartered in Vienna, Austria. The company focuses on research, development and global sales of innovative treatment solutions and specializes in therapies for rare diseases and intensive care. In early July, AOP Health signed an agreement with Leukos Biotech, a spin-off company founded by the Barcelona-based Josep Carreras Leukaemia Research Institute. The agreement signed by AOP Health covers the option for developments of the newly discovered chemical substance within any treatable indication, not limited to oncological or rare diseases.

Luis Ruiz-Avila, Chief Executive Officer Leukos Biotech

Copyright: Albert Mollon

Agreement sets basis for new areas of therapy

At first, AOP Health will focus on the development of treatment options for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS). Both are special disease types of leukemia that often start in the bone marrow. Agnes Kohl, Chief Business Officer of AOP Orphan Pharmaceuticals GmbH, Member of the AOP Health Group explains: “Based on positive data, our plan is to expand the development for further orphan indications even outside of AML and MDS at a later stage. With this agreement, we may be able to broaden the portfolio within our therapeutic areas offering even more treatment options for patients.”

Development in cooperation with Leukos

As AOP Health focuses on rare, hemato-oncological cancers and has many years of experience in the development and commercialization of hemato-oncological treatments, the company will drive the further development of the substance in cooperation with Leukos based on a new mode of action. This could potentially turn into a milestone in the treatment of many blood cancer and other cancer patients. Luis Ruiz-Avila, Chief Executive Officer of Leukos Biotech: “We focus on developing new treatments for a wide variety of tumors. We were born to transform excellent science from the Josep Carreras Leukaemia Research Institute into valuable products for cancer patients in need, and this agreement is a very significant step in that direction. We are convinced that AOP Health is the right partner to turn this promising, novel mechanism of action into a clinical reality for the benefit of patients in a wide variety of unmet medical needs”.

About AOP Health

The AOP Health Group incorporates several companies including AOP Orphan Pharmaceuticals GmbH with its seat in Vienna, Austria (“AOP Health”). The AOP Health Group is the European pioneer for integrated therapies for rare diseases and in critical care. Over the past 25 years, the Group has become an established provider of integrated therapy solutions operating from its headquarters in Vienna, its subsidiaries and representative offices throughout Europe and the Middle East, as well as through partners worldwide. This development has been made possible by a continually high level of investment in research and development on the one hand and a highly consistent and pragmatic orientation towards the needs of all its stakeholders on the other – especially the patients and their families as well as also the healthcare professionals treating them.

About Leukos

Leukos Biotech, SL (Leukos) is a spin-off company from the Josep Carreras Leukaemia Research Institute incorporated in Barcelona in 2015. The company is developing new treatments and diagnostic tools for a wide variety of tumors targeting the serotonin receptor HTR1B, which antitumoral potential was first described and patented by Leukos’ founder Dr. Ruth Risueño in her laboratory at the Josep Carreras Research Institute. Leukos’ main financial support is from private and institutional investors. The main shareholders are Inveready, CDTI Innvierte and the Josep Carreras Foundation. Besides investors’ support, Leukos has received non-dilutive grants and loans from the Catalan Government, the Spanish Government and the European Union in various programs.

About the Josep Carreras Foundation

The Josep Carreras Leukaemia Foundation was established in 1988 with the intention of contributing to finding a definitive cure for this disease. Its efforts are concentrated on four basic areas: administering the Spanish Bone Marrow Donor Registry (REDMO), scientific research, carried out by the Josep Carreras Leukaemia Research Institute, patient guidance through an online patient consultation channel, and reception apartments for patients who need to undergo treatment and have to spend a long time far from home.

About the Josep Carreras Leukaemia Research Institute

The Josep Carreras Leukaemia Research Institute, a public centre pertaining to the Generalitat de Catalunya’s CERCA network, was established in 2010 with the aim of furthering biomedical research and personalised medicine in the field of leukaemia and other onco-hematological diseases. It is the first research centre in Europe exclusively focussed on leukaemia and malignant blood diseases, and one of the very few in the world. The Josep Carreras Institutes has three coordinated but independent scientific campuses: University of Barcelona Hospital Clínic Campus, The Catalan Institute of Oncology/Germans Trias i Pujol Campus, and the Sant Pau – Autonomous University of Barcelona (UAB) Campus

About Inveready

Inveready is a leading alternative asset manager in Spain – investing in early-stage VC, growth VC, venture debt, strategic equity in listed companies, infrastructure and private equity – providing financing solutions to companies throughout their life-cycle. Founded in 2008, Inveready counts on 200 active companies, and more than €1bn of assets under management. Inveready has been investing in companies in the Life Sciences sector since 2008. Notable investments in this vertical are Atrys Health (listed on the Spanish market), EDESA Biotech (listed on Nasdaq), AVX Pharma (sold to Aerie Biotech) and PaloBiofarma (licensing agreement with Novartis). Inveready is headquartered in San Sebastian, and has other offices in Barcelona and Madrid. It has been recognized on multiple occasions by ASCRI and Preqin for the return on its funds and transactions (For more information, visit www.inveready.com).

Mag Nina Roth, MAS
nina.roth@aop-health.com

AOP Health
Needs. Science. Trust.

AOP Orphan Pharmaceuticals GmbH
Member of the AOP Health Group

Leopold-Ungar-Platz 2, 1190 Vienna, Austria
aop-health.com

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/f096650f-dbfc-4165-854b-63345d24a713

https://www.globenewswire.com/NewsRoom/AttachmentNg/9aa481fe-91da-4609-8570-2e9a1012c392

Posted on

Zenas BioPharma Obtains IND Approval in China for Phase 1/2 Study of ZB001 for the Treatment of Thyroid Eye Disease  

WALTHAM, Mass and SHANGHAI, China, July 31, 2022 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of immune-based therapies for patients in need around the world, announced that it has received approval of its Investigational New Drug (IND) application from the National Medical Products Administration (NMPA) of China for the initiation of a Phase 1/2 clinical study of ZB001 for the treatment of Thyroid Eye Disease (TED). The main objective of the Phase 1/2 is to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of ZB001.

TED is a debilitating vison-threatening autoimmune disease that causes inflammation and fibrosis within the orbit of the eye. With no approved therapies for TED patients in China, treatment options are limited and often involve high doses of steroids associated with serious side effects or surgical intervention. ZB001 is a differentiated humanized monoclonal antibody targeting insulin-like growth factor 1 receptor (IGF-1R) intended for the treatment of TED.

“We are proud that the IND application for ZB001 was approved by the NMPA about two months following its submission, highlighting our team’s unique ability to efficiently execute on our development programs,” said Hua Mu, MD, PhD, Chief Executive Officer at Zenas. “We are excited to work with leading clinical experts in China to accelerate the development of ZB001 to address the significant unmet clinical need in thyroid eye disease.”

Zenas BioPharma licensed the exclusive rights to develop, manufacture and commercialize ZB001 (Viridian VRDN-001) and other compounds targeting IGF-1R in non-oncology indications in the greater China area from Viridian Therapeutics, Inc. (Viridian) in October 2020. After submitting an IND for VRDN-001 to the U.S. Food and Drug Administration in October 2021, Viridian initiated a Phase 1/2 clinical trial in December 2021 to evaluate proof of concept in TED patients in North America and released encouraging interim healthy volunteer data suggesting robust activity with excellent safety and tolerability of the candidate product.

About Zenas BioPharma

Zenas BioPharma is a global biopharmaceutical company based in the USA and China committed to becoming a leader in the development and commercialization of immune-based therapies for patients in the US, China and around the world. Zenas is rapidly advancing a deep pipeline of innovative therapeutics that continues to grow through our successful business development strategy. Our experienced leadership team and network of business partners drive operational excellence to deliver potentially transformative therapies to improve the lives of those facing autoimmune and rare diseases. For more information about Zenas BioPharma, please visit www.zenasbio.com and follow us on Twitter at @ZenasBioPharma and LinkedIn.

Investor and Media Contact:
Joe Farmer
Zenas BioPharma
IR@zenasbio.com

Posted on

Registration for ‘Sijil Perdagangan Brunei’ Examination Is Open

Registration for Sijil Perdagangan Brunei or Brunei Business Certificate, SPB Examination for November 2022 is now open. The Examinations Department, Ministry of Education informed that the examination is open to candidates who have been registered under the Advanced Education Division, BPL and private candidates.

Registration forms can be obtained from the Examinations Department, Ministry of Education during office hours. The Examinations Department will only accept completed application forms and payment every Monday until Thursday from 8 to 11 in the morning and 1:30 to 3 in the afternoon, while on Saturday, from 8 until 10 in the morning. The submission date for completed forms is no later than 22 September 2022.

Source: Radio Television Brunei

Posted on

Festive Stage

Festive stage events held in conjunction with His Majesty's 76th Birthday Celebration lowered its curtain last night.

The festive stage in Belait District featured religious performances organised by the Mukim Penghulu, Village Head and Longhouse Chief Body, PEKERUPA. Present was Awang Mohamad Yassin bin Haji Ahmed, Acting Belait District Officer.

The Hijrah Night performance conducted by Nur Islam F-M enlivened the festive stage in Temburong District. In attendance was Awang Haji Azman bin Haji Abdul Rahim, Acting Director of Radio Televisyen Brunei. The event included the reading of Sayyidul Istighfar and Selawat Tafrijiyyah, tazkirah, Tausyeh performance and quiz.

Meanwhile in the capital, the 'Penggiat Kesenian Syiar Islam' programme was held, which included Al-Quran reading with tarannum by Abdul Muin bin Haji Abdul Hamid, champion Qari of the 2019 National Youth Musabaqah, and Dayangku Nurul Sakinah Adawiyah Pengiran Ainolazahar, second runner up of the 2020 National Youth Musabaqah Tilawatil Quran Belia.

The festive stage in Tutong District featured religious performances organised by Tutong District Mosque Muslimah. Among the performances include Selawat Tafrijiyah, Tadabbur Al-Quran and nasyid.

Source: Radio Television Brunei

Posted on

Reopening Of Land Border

The land borders are fully opened starting yesterday after more than 2 years of closure following the outbreak of the COVID-19 pandemic. The public who wish to travel overseas are encouraged to be fully vaccinated and buy insurance protection for COVID-19. During the initial stage of the border opening, operating hours for all land control posts is from 6 in the morning to 6 in the afternoon daily. RTB crews took a closer look at several land control posts in the country.

The Sungai Tujuh Control Post observed very light traffic. Two vehicles inspection counters were opened at the entry and exit areas. The Royal Customs and Excise Department and Department of Immigration and National Registration are ready to open additional counters, depending on the needs and current situations.

Meanwhile, at Kuala Lurah Control Post, several relevant agencies are seen conducting monitoring to ensure the entry and exit process runs smoothly by prioritising safety factors. The public is urged to register and apply for the Exit and Entry System and to pay the Service Charge of 3 dollars per person for a one-way trip, one day before travelling.

The Labu Control Post in Temburong District is operating as usual with a number of Brunei vehicles exiting the country. Further information on the border reopening is available at www.pmo.gov.bn/travelportal or contact hotline 120 or email to travel application at jpm.gov.bn.

Source: Radio Television Brunei

Posted on

Myanmar, South China Sea to Divide, Dominate ASEAN Summit

Foreign Ministers from the 10-member Association of Southeast Asian Nations (ASEAN) will try and thrash out their differences, ranging from the conflict in Myanmar, to the disputed South China Sea, to admitting East Timor to the bloc, when they meet in Phnom Penh, Cambodia this week.

Bradley Murg, a senior adviser to the Cambodian Institute for Cooperation and Peace said the Philippines is expected to raise the South China Sea issue under new President Ferdinand Marcos Jr. who is reasserting Manila’s 2016 arbitration award over China at The Hague. That ruling invalidated Beijing’s territorial claims in the waterway.

Ten years ago, when Phnom Penh last held the chair, foreign ministers failed to issue a joint communique for the first time in ASEAN’s 45-year history after Cambodia objected to mentioning China and its confrontations with the Philippines and Vietnam in the South China Sea.

It was considered a major diplomatic blunder for the host nation and divisions have emerged ever since with Cambodia, a major benefactor of Beijing’s largesse, often seen by observers as a Chinese proxy within the group.

“This is obviously something that Cambodia’s going to be concerned about in light of the fact that Cambodia’s last chairmanship ended with significant acrimony in light of the inability to reach an agreement,” Murg said.

Most ASEAN countries want a united front on a code of conduct for the South China Sea, but critics claim Beijing, which wants to handle negotiations on a country-by-country basis, has used Cambodia to thwart progress on an agreement and to block diplomatic opposition to its maritime claims.

“This is not the topic that Cambodia really wants to be discussing at this ASEAN summit but if the Philippines decides to move forward, and it appears that it’s willing to do so, that could very much dominate the week,” Murg added.

Analysts also said efforts by Prime Minister Hun Sen, as this year’s Chair, to normalize ties between ASEAN and the Myanmar junta had also heightened divisions, made all the worse by last week’s execution of four democracy advocates.

Monday the Myanmar military extended its state of emergency by six months saying promised elections could only take place once a “stable and peaceful” environment had been restored.

“The Myanmar question’s going to continue being on the table, despite Cambodia’s best efforts it appears that the regime continues to consolidate, and that the ASEAN approach alone is simply not going to be sufficient,” Murg said.

He said there was an increased desire by most ASEAN states for a more global approach to Myanmar and this ASEAN meeting would enable them to explore that, but the divisions are stark.

Analysts have also said a troika has emerged with Indonesia, Malaysia and Brunei, who share religious sympathies with Myanmar’s Muslim Rohingya, opposed to bringing the junta back into the group after it was banned in response to the February 2021 coup.

ASEAN Parliamentarians for Human Rights has accused Thailand, Cambodia and Laos of aiding the junta and on Monday the group urged all ASEAN states to recognize the National Unity Government of Myanmar, established by supporters of the ousted leader Aung San Suu Kyi.

U.S. Secretary of State Antony Blinken added his voice saying he was disappointed with ASEAN for failing to apply any pressure on the junta and its leader, Min Aung Hlaing.

“I think it’s unfortunately safe to say that we’ve seen no positive movement,” Blinken told a news conference in Bangkok. “On the contrary, we continue to see the repression of the Burmese people who continue to see violence perpetrated by the regime.”

Ten additional countries will attend the summit as dialogue partners, including Australia, Japan, India, South Korea. Russian Foreign Minister Sergey Lavrov and Blinken will also attend but the U.S. State department has said the pair are not scheduled to meet.

“There are obviously many major issues to be dealt with, including Myanmar and a potential showdown between foreign minister Lavrov from Russia and Antony Blinken,” said David Totten, managing director of Emerging Markets Consulting in Phnom Penh.

“That will be an attention grabber, but I also hope they move on the economies,” he said.

ASEAN economies were devastated by the COVID-19 pandemic, and global inflation, spurred in part by Russia’s invasion of Ukraine, has sharply reduced purchasing power and priced essential items like rice beyond ordinary household budgets.

The number of Southeast Asians living in extreme poverty — defined as less than $1.90 a day — had eased before COVID-19 erupted, falling to 14.9 million in 2019, from 21.2 million people in 2017.

But the Asian Development Bank says the pandemic has pushed nearly five million people back into extreme poverty.

“Poverty is still a big problem in Southeast Asia and people are struggling. The cost of fuel has skyrocketed as has the price of getting goods to market,” Totten said. “Industries like tourism still haven’t recovered and foreign investment needs to make a return to the region.”

Also on the agenda is East Timor, also known as Timor Leste, which has lobbied hard to become the 11th member of the group and has the support of nearly all member states.

Sources say there were two concerns about Dili’s application; its ability to fund the logistics required as an ASEAN member and its close relationship with Beijing.

“There is a fear that Timor Leste will become another voice for China within ASEAN and most of the members don’t want that. Those objections are being led by Singapore,” an analyst close to the Timorese camp said. “China has enough access through Cambodia.”

Source: Voice of America

Posted on

Investiture of State Decorations

His Majesty Sultan Haji Hassanal Bolkiah Mu'izzaddin Waddaulah ibni Al-Marhum Sultan Haji Omar 'Ali Saifuddien Sa'adul Khairi Waddien, Sultan and Yang Di-Pertuan of Brunei Darussalam conferred Brunei Darussalam State Decorations to 266 recipients in conjunction with His Majesty's 76th Birthday Celebration. The ceremony took place yesterday afternoon at Balai Singgahsana Indera Kenchana, Istana Nurul Iman.

Also present was His Majesty's sons and brothers:

- His Royal Highness Prince Haji Al-Muhtadee Billah, the Crown Prince and Senior Minister at the Prime Minister's Office;

- His Royal Highness Prince 'Abdul Malik;

- His Royal Highness Prince 'Abdul Mateen;

- His Royal Highness Prince Mohamed Bolkiah;

- and His Royal Highness Prince Haji Jefri Bolkiah.

His Majesty first conferred The Most Blessed Order of Setia Negara Brunei, Third Class, SNB to Pengiran Hajah Siti Nirmala Binti Pengiran Haji Mohamad, Permanent Secretary at the Prime Minister's Office.

His Majesty then conferred The Most Honourable Order of Seri Paduka Mahkota Brunei, Third Class, SMB to 50 recipients comprising government officers and from the private sector. The investiture of state decorations reflected the Monarch's appreciation towards the recipients' contribution in various fields of national development.

6 other recipients were conferred The Most Eminent Order of Islam Brunei, Fourth Class, SUB.

The Monarch also conferred The Most Blessed Order of Setia Negara Brunei, Fourth Class, PSB to 187 recipients. The investiture acts as a motivation for officers and staff at the government and private sectors to continue serving the country.

The Most Eminent Order of Islam Brunei, Fifth Class, PUB was conferred to 22 recipients.

Doa Selamat was read by Yang Berhormat Pehin Datu Seri Maharaja Dato Paduka Seri Setia Doctor Ustaz Haji Awang Abdul Aziz bin Juned, the State Mufti.

The investiture was attended by Pengiran-Pengiran Cheteria; Cabinet Ministers; Members of Council; Deputy Ministers; Pengiran-Pengiran Peranakan; Pehin-Pehin Manteri; Manteri-Manteri Hulubalang; Ambassadors; High Commissioners; Permanent Secretaries; Deputy Permanent Secretaries; and Heads of Departments.

Source: Radio Television Brunei

Posted on

Increase Local Rice Production

Wasan Milling Company Sendirian Berhad, a new commercial entity wholly owned by Darussalam Assets Sendirian Berhad has taken over the operations of the Government rice milling facility located in Wasan Agricultural Development Area, starting yesterday. The rice milling services were previously under the purview of the Department of Agriculture and AgriFood, Ministry of Primary Resources and Tourism.

The corporatisation initiative driven by the Ministry of Primary Resources and Tourism and facilitated by Darussalam Assets will be implemented in phases and aimed to elevate the capabilities of Brunei Darussalam's rice production to complement the nation's growing needs. With the corporatisation of rice mill services, Wasan Milling Company will be able to create employment opportunities for locals in the agribusiness industry and provide specialisation in operating rice milling machinery and equipment that are in line with international best practices.

Source: Radio Television Brunei

Proudly powered by WordPress